David Weill

David Weill

Director/Board Member at TRANSMEDICS GROUP, INC.

Net worth: 1 M $ as of 2024-03-30

60 year
Consumer Services
Health Technology

Profile

David Weill is currently the Director at TransMedics, Inc., an Independent Director at TransMedics Group, Inc., and the Principal at Weill Consulting Group.
Previously, he served as the Director of the Lung & Heart Transplant Program at Stanford University from 2005 to 2016.
He also held the position of Director at Stanford Center For Advanced Lung Diseases and Director of the Lung & Heart Lung Transplant Program at Stanford University Medical Center during the same period.
Dr. Weill completed his undergraduate degree at Tulane University in 1985 and obtained his doctorate from Tulane University School of Medicine in 1990.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-08-28 13,693 ( 0.04% ) 1 M $ 2024-03-30

David Weill active positions

CompaniesPositionStart
TRANSMEDICS GROUP, INC. Director/Board Member 2018-12-31
Weill Consulting Group Corporate Officer/Principal 2015-12-31
Director/Board Member -
All active positions of David Weill

Former positions of David Weill

CompaniesPositionEnd
Stanford University Medical Center Corporate Officer/Principal 2015-12-31
Stanford Center For Advanced Lung Diseases Director/Board Member -
See the detail of David Weill's experience

Training of David Weill

Tulane University (Louisiana) Undergraduate Degree
Tulane University School of Medicine Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Weill's experience

Connections

99

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
TRANSMEDICS GROUP, INC.

Health Technology

Private companies4

Health Technology

Weill Consulting Group

Stanford Center For Advanced Lung Diseases

Stanford University Medical Center

See company connections